Northern Trust
TFFP

Northern Trust’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Northern Trust’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,970
Closed -$17.2K – 4560
2023
Q3 		$17.2K Hold
1,970
– – ﹤0.01% 4354
2023
Q2 		$23.1K Hold
1,970
– – ﹤0.01% 4377
2023
Q1 		$33.7K Buy
1,970
+406
+26% +$8.8K ﹤0.01% 4354
2022
Q4 		$41.1K Hold
1,564
– – ﹤0.01% 4331
2022
Q3 		$159K Buy
1,564
+174
+13% +$23.5K ﹤0.01% 3969
2022
Q2 		$196K Buy
1,390
+21
+2% +$2.93K ﹤0.01% 3935
2022
Q1 		$216K Sell
1,369
-63
-4% -$10.2K ﹤0.01% 4107
2021
Q4 		$318K Sell
1,432
-289
-17% -$55.9K ﹤0.01% 3998
2021
Q3 		$332K Buy
1,721
+599
+53% +$127K ﹤0.01% 3934
2021
Q2 		$269K Buy
1,122
+261
+30% +$71.6K ﹤0.01% 4007
2021
Q1 		$292K Buy
861
+4
+0.5% +$1.63K ﹤0.01% 3990
2020
Q4 		$307K Sell
857
-20
-2% -$7.7K ﹤0.01% 3857
2020
Q3 		$405K Buy
+877
New +$248K ﹤0.01% 3659

Other funds holding TFFP

CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Northern Trust's TFFP Position: Q4 2023 in Review

Northern Trust sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2023, closing a stake of 1,970 shares — an estimated $17.2K sold.

Northern Trust first reported a position in TFFP in Q3 2020 and held it in 13 quarters. The position peaked at $405K in Q3 2020. 23 funds tracked by Wall St. Rank hold TFFP as of Q4 2023.

  • Northern Trust reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Northern Trust sold 1,970 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $17.2K.
  • Northern Trust first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 13 quarters.
  • Northern Trust's TFF Pharmaceuticals, Inc. Common Stock position peaked at $405K in Q3 2020.
  • 23 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Northern Trust's 13F filing for Q4 2023, filed 13 Feb 2024.